癌症免疫疗法杂志（JITC）是经同行评审的开放存取期刊，是癌症免疫疗法学会（SITC）的在线杂志。该杂志发表有关肿瘤免疫学和癌症免疫疗法各个方面的文章，并以此为目标，在这个快速发展的领域中，丰富了众多利益相关者之间的交流并增进了科学理解。感兴趣的主题范围广泛，涵盖基础科学-翻译-临床领域，包括肿瘤与宿主的相互作用，肿瘤微环境，动物模型，预测性和预后性免疫生物标记物，新型药物和细胞疗法，疫苗，基于免疫的联合疗法以及免疫相关的毒性。 JITC发表高质量的原创研究文章，文献评论，立场文件和实践指南以及案例报告；期刊也可以委托邀请评论。这些文章在一起使JITC成为肿瘤免疫学和癌症免疫疗法研究的领先论坛。

Journal for ImmunoTherapy of Cancer (JITC) is the open access, peer reviewed, online journal of the Society for Immunotherapy of Cancer (SITC). The journal publishes articles on all aspects of tumor immunology and cancer immunotherapy and, in doing so, aims to enrich communication and advance scientific understanding among the many stakeholders in this rapidly evolving field. Topics of interest range widely across the basic science-translational-clinical spectrum and include tumor-host interactions, the tumor microenvironment, animal models, predictive and prognostic immune biomarkers, novel pharmaceutical and cellular therapies, vaccines, combination immune-based therapies, and immune-related toxicity. JITC publishes high quality original research articles, literature reviews, position papers and practice guidelines, and case reports; invited commentaries may also be commissioned by the journal. Together, these articles make JITC the leading forum for research in tumor immunology and cancer immunotherapy. 。